Pharmacological Activity of Motugivatrep, a Novel Antagonist of Transient Receptor Potential Cation Channel Subfamily V Member 1
Biological and Pharmaceutical Bulletin · 2026
DOI: 10.1248/bpb.b26-00200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2026. Verfasst von Tomoka Uemura und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research & Development Division, Senju Pharmaceutical Co., Ltd., 6-4-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan. Hauptthemen laut MEDLINE: TRPV Cation Channels. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research & Development Division, Senju Pharmaceutical Co., Ltd., 6-4-3 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan.
- Research Division, Mochida Pharmaceutical Co., Ltd., 722 Uenohara, Jimba, Gotemba, Shizuoka 412-8524, Japan.
Zitieren
APA
Uemura, T., Uchida, H., Higashi, C., Amano, K. I., & Kanda, A. (2026). Pharmacological Activity of Motugivatrep, a Novel Antagonist of Transient Receptor Potential Cation Channel Subfamily V Member 1. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b26-00200
Vancouver
Uemura T, Uchida H, Higashi C, Amano KI, Kanda A. Pharmacological Activity of Motugivatrep, a Novel Antagonist of Transient Receptor Potential Cation Channel Subfamily V Member 1. Biological and Pharmaceutical Bulletin. 2026. doi:10.1248/bpb.b26-00200
BibTeX
@article{Uemura2026,
author = {Uemura, Tomoka and Uchida, Hideharu and Higashi, Chika and Amano, Ken-Ichi and Kanda, Atsuhiro},
title = {Pharmacological Activity of Motugivatrep, a Novel Antagonist of Transient Receptor Potential Cation Channel Subfamily V Member 1},
journal = {Biological and Pharmaceutical Bulletin},
year = {2026},
doi = {10.1248/bpb.b26-00200}
}
EUVIMED